ID

28402

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver events

Keywords

  1. 11/10/17 11/10/17 -
  2. 16/10/17 16/10/17 -
  3. 16/10/17 16/10/17 -
  4. 23/10/17 23/10/17 -
  5. 11/01/18 11/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

11 gennaio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Descrizione

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?

[1] ALT (alanine aminotransferase)
Descrizione

alanine aminotransferase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201836
[2] AST (aspartate aminotransferase)
Descrizione

aspartate aminotransferase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201899
[3] Total bilirubin
Descrizione

Total bilirubin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201913
[4] Alkaline phosphatase
Descrizione

Alkaline phosphatase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201850
[OT] Other
Descrizione

Other liver chemistry result

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0587081
Liver events
Descrizione

Liver events

2. Is the subject age 55 or older?
Descrizione

subject age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
3. If female, is the subject pregnant?
Descrizione

If yes, ensure Pregnancy Notification Form has been completed.

Tipo di dati

text

Alias
UMLS CUI [1]
C0549206
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Descrizione

diagnostic imaging of liver or hepatobiliary system

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1711359
UMLS CUI [1,2]
C0011923
UMLS CUI [1,3]
C0023884
4. If diagnostic imaging tests were performed, were the results normal?
Descrizione

If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Event form.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1711359
UMLS CUI [1,2]
C0011923
UMLS CUI [1,3]
C0023884
UMLS CUI [1,4]
C1254595
5. Were any liver biopsies performed?
Descrizione

If yes, complete Liver Biopsy form.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0193388
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Descrizione

If yes, record on the appropriate Concomitant Medication form.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0002346
UMLS CUI [1,2]
C0242295
UMLS CUI [1,3]
C0281875
7. Did the subject fast or undergo significant dietary change in the past week?
Descrizione

dietary change

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3671772
Evaluation interval code
Descrizione

[hidden]

Tipo di dati

text

Alias
UMLS CUI [1]
C2985767

Similar models

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
alanine aminotransferase
Item
[1] ALT (alanine aminotransferase)
boolean
C0201836 (UMLS CUI [1])
aspartate aminotransferase
Item
[2] AST (aspartate aminotransferase)
boolean
C0201899 (UMLS CUI [1])
Total bilirubin
Item
[3] Total bilirubin
boolean
C0201913 (UMLS CUI [1])
Alkaline phosphatase
Item
[4] Alkaline phosphatase
boolean
C0201850 (UMLS CUI [1])
Other liver chemistry result
Item
[OT] Other
boolean
C0008000 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Item Group
Liver events
subject age
Item
2. Is the subject age 55 or older?
boolean
C0001779 (UMLS CUI [1])
Item
3. If female, is the subject pregnant?
text
C0549206 (UMLS CUI [1])
Code List
3. If female, is the subject pregnant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not applicable (X)
diagnostic imaging of liver or hepatobiliary system
Item
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
C1711359 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
diagnostic imaging of liver or hepatobiliary system results
Item
4. If diagnostic imaging tests were performed, were the results normal?
boolean
C1711359 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
C1254595 (UMLS CUI [1,4])
liver biopsies
Item
5. Were any liver biopsies performed?
boolean
C0193388 (UMLS CUI [1])
complementary or alternative medicines, supplements, illicit drugs
Item
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
C0002346 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0281875 (UMLS CUI [1,3])
dietary change
Item
7. Did the subject fast or undergo significant dietary change in the past week?
boolean
C3671772 (UMLS CUI [1])
Evaluation interval code
Item
Evaluation interval code
text
C2985767 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial